Neotherix Logo
Current News
Open All News Items  |  Close All News Items  |  Archived News  |  RSS Feed Subscribe to our RSS news feed

Current news items from Neotherix are listed below. See the Archived News page for older articles.

22/06/17 PhotoTherix™ project update at Medical Technologies IKC and Regener8 Annual Conference 2017
22/06/17 Neotherix presenting at Medical Technologies IKC and Regener8 Annual Conference 2017
19/06/17 Neotherix on the programme for UK Society for Biomaterials 2017
24/04/17 Full Sector Panel announced for Leeds City Region MedTech event
20/04/17 Neotherix announced as part of the Sector Panel at Leeds City Region MedTech event
23/03/17 Neotherix participates in Leeds City Region's Science and Innovation Audit
21/02/17 EktoTherix™: First in Man clinical investigation recruitment completed
06/02/17 Medical Technologies IKC funding for new PhotoTherix™ project
11/11/16 Neotherix to exhibit at Venturefest Yorkshire 2016
11/10/16 New tendon repair review
26/09/16 Neotherix selected to pitch at 2016 BioCap life science and investment conference
16/09/16 Mike Raxworthy to chair seminar at Venturefest Yorkshire 2016
14/09/16 New research paper published with Neotherix author
31/08/16 EktoTherix™: Additional site now recruiting patients to clinical investigation

Neotherix are pleased to announce the addition of a third site to the First in Man clinical investigation of EktoTherix™ Tissue Repair Scaffold. James Cook University Hospital (South Tees Hospitals NHS Foundation Trust) commenced participation on 25 July, and the clinical team there have already recruited one additional patient to the study.

The addition of James Cook University Hospital supports the work of the two original sites, York Hospital and Scarborough Hospital (both York Teaching Hospital NHS Foundation Trust), and is expected to significantly enhance the rate of patient recruitment to the study.

As reported previously, this initial safety study assesses EktoTherix for the treatment of full-thickness, dermatologic wounds created by the surgical removal of non-melanoma skin cancers. Study outcomes following the application of EktoTherix Tissue Repair Scaffold to wounds resulting from these surgical excisions are recorded. The scaffold is expected to promote repair of the wound by the patients' own cells, enhancing healing and improving quality of repair. The tissue scaffold is designed to be completely resorbed by the body during the healing process so that there is no need for removal when the wound has healed.

Although the primary objective is to assess the safety of EktoTherix in humans, a secondary objective is to evaluate its clinical performance. The ability of EktoTherix to increase incidence of complete healing and result in an overall better cosmetic result (cosmesis) of the healed wound will be monitored.

For more information on the study see the EktoTherix study record on ClinicalTrials.gov Link to external web site.

Close  |  Top of Page
22/04/16 Neotherix achieves ISO 13485 certification milestone
15/04/16 Neotherix selected to join Hiscox Business Club
10/03/16 Neotherix included in Super North supplement for The Times
04/02/16 Mike Raxworthy appointed to RAEng Visiting Professorship at University of Leeds
02/12/15 Mike Raxworthy appointed External Examiner
27/11/15 RegeniTherix™ Wound Theranostic System wins Bionow Project of the Year Award
24/11/15 RegeniTherix™ Wound Theranostic System short-listed for Bionow Project of the Year Award
12/10/15 Neotherix presenting at World Conference on Regenerative Medicine 2015
22/09/15 Neotherix selected to pitch at 2015 BioCap conference
03/09/15 Neotherix presenting at Regener8 Annual Conference as part of MEIbioeng15
10/06/15 Neotherix in new collaboration with the School of Dentistry, University of Leeds
08/06/15 New publication on the use of Neotherix scaffold technology to create 3D tissue models
03/06/15 EktoTherix™: First Patients Recruited
12/05/15 Neotherix presenting at Regener8/Science City York Technology Digests - Regenerative Scaffolds
17/04/15 Neotherix attending 2015 BioSynergy Conference
04/03/15 Super Cells exhibition launch event
11/02/15 UEA Industrial CASE project undergoes first interim review
09/02/15 New publication from Neotherix scientist
19/12/14 Neotherix becomes Bionow member
21/11/14 Year in Industry Intern joins Neotherix team
25/09/14 Neotherix is a Medipex NHS Innovation Awards 2014 Finalist
16/09/14 Neotherix attending the Regener8 Annual Conference 2014
22/08/14 Congratulations to Neotherix-supported CASE student
04/06/14 Applicants sought for UEA CASE PhD studentship with Neotherix
02/05/14 Key patent granted in Japan
30/04/14 Presentations from Nano4Life event now available
14/03/14 Case study published on collaborative project between Neotherix and the University of Manchester
05/03/14 Neotherix presenting at Nano4Life 6th Annual Conference and Exhibition
26/02/14 Neotherix attending Nanofibres to Nanocomposites III conference
27/01/14 Neotherix attending 2014 BioSynergy Conference
21/01/14 Neotherix listed on map of UK Regenerative Medicine landscape
09/01/14 MeDe Innovation Launch and iMBE Annual Conference
© Copyright 2007-2017 Neotherix Ltd. All rights reserved.